Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason M Uslaner

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Behavioural Brain Research|March 25, 2015
The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse modelVanita Puri, Xiaohai Wang, Joshua D Vardigan, et al.
Journal of Neurochemistry|March 19, 2003
Amphetamine-induced c-fos mRNA expression in the caudate-putamen and subthalamic nucleus: interactions between dose, environment, and neuronal phenotypeJason M Uslaner, Camille S Norton, Stanley J Watson, et al.
Pharmacology, Biochemistry, and Behavior|February 4, 2010
MK-801 produces a deficit in sucrose preference that is reversed by clozapine, D-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: relevance to negative symptoms associated with schizophrenia?Joshua D Vardigan, Sarah L Huszar, Caitlyn H McNaughton, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 9, 2015
The M1 Muscarinic Positive Allosteric Modulator PQCA Improves Performance on Translatable Tests of Memory and Attention in Rhesus MonkeysHenry S Lange, Christopher E Cannon, Jason T Drott, et al.
Neuropharmacology|June 5, 2012
The nicotinic α7 receptor agonist GTS-21 improves cognitive performance in ketamine impaired rhesus monkeysChristopher E Cannon, Vanita Puri, Jeffrey A Vivian, et al.
Pharmacology, Biochemistry, and Behavior|December 6, 2011
The mGluR7 allosteric agonist AMN082 produces antidepressant-like effects by modulating glutamatergic signalingStefania Risso Bradley, Jason M Uslaner, Rose B Flick, et al.
Neuropharmacology|August 14, 2021
Effects of a novel M4 muscarinic positive allosteric modulator on behavior and cognitive deficits relevant to Alzheimer's disease and schizophrenia in rhesus monkeyHenry S Lange, Joshua D Vardigan, Christopher E Cannon, et al.
Psychopharmacology|April 28, 2016
Behavioral and qEEG effects of the PDE10A inhibitor THPP-1 in a novel rhesus model of antipsychotic activityJoshua D Vardigan, Henry S Lange, Spencer J Tye, et al.
Psychopharmacology|August 27, 2009
Combined administration of an mGlu2/3 receptor agonist and a 5-HT 2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulantsJason M Uslaner, Sean M Smith, Sarah L Huszar, et al.
Neuroimage|November 3, 2015
fMRI study of olfaction in the olfactory bulb and high olfactory structures of rats: Insight into their roles in habituationFuqiang Zhao, Xiaohai Wang, Hatim A Zariwala, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Behavioural Brain Research|March 25, 2015
The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse modelVanita Puri, Xiaohai Wang, Joshua D Vardigan, et al.
Journal of Neurochemistry|March 19, 2003
Amphetamine-induced c-fos mRNA expression in the caudate-putamen and subthalamic nucleus: interactions between dose, environment, and neuronal phenotypeJason M Uslaner, Camille S Norton, Stanley J Watson, et al.
Pharmacology, Biochemistry, and Behavior|February 4, 2010
MK-801 produces a deficit in sucrose preference that is reversed by clozapine, D-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: relevance to negative symptoms associated with schizophrenia?Joshua D Vardigan, Sarah L Huszar, Caitlyn H McNaughton, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 9, 2015
The M1 Muscarinic Positive Allosteric Modulator PQCA Improves Performance on Translatable Tests of Memory and Attention in Rhesus MonkeysHenry S Lange, Christopher E Cannon, Jason T Drott, et al.
Neuropharmacology|June 5, 2012
The nicotinic α7 receptor agonist GTS-21 improves cognitive performance in ketamine impaired rhesus monkeysChristopher E Cannon, Vanita Puri, Jeffrey A Vivian, et al.
Pharmacology, Biochemistry, and Behavior|December 6, 2011
The mGluR7 allosteric agonist AMN082 produces antidepressant-like effects by modulating glutamatergic signalingStefania Risso Bradley, Jason M Uslaner, Rose B Flick, et al.
Neuropharmacology|August 14, 2021
Effects of a novel M4 muscarinic positive allosteric modulator on behavior and cognitive deficits relevant to Alzheimer's disease and schizophrenia in rhesus monkeyHenry S Lange, Joshua D Vardigan, Christopher E Cannon, et al.
Psychopharmacology|April 28, 2016
Behavioral and qEEG effects of the PDE10A inhibitor THPP-1 in a novel rhesus model of antipsychotic activityJoshua D Vardigan, Henry S Lange, Spencer J Tye, et al.
Psychopharmacology|August 27, 2009
Combined administration of an mGlu2/3 receptor agonist and a 5-HT 2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulantsJason M Uslaner, Sean M Smith, Sarah L Huszar, et al.
Neuroimage|November 3, 2015
fMRI study of olfaction in the olfactory bulb and high olfactory structures of rats: Insight into their roles in habituationFuqiang Zhao, Xiaohai Wang, Hatim A Zariwala, et al.
Pageof 8